IL3RA and acute myeloid leukemia: Yao et al. (2019) presented a 25-year-old patient with FUS-ERG + AML who relapsed after allogeneic stem cell transplantation (alloHSCT) and received donor-derived CD123 CAR-T cells as part of the conditioning regimen for haploidentical HSCT.